BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alonzi T, Aiello A, Petrone L, Najafi Fard S, D'Eletto M, Falasca L, Nardacci R, Rossin F, Delogu G, Castilletti C, Capobianchi MR, Ippolito G, Piacentini M, Goletti D. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy. Cells 2021;11:52. [PMID: 35011614 DOI: 10.3390/cells11010052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Alonzi T, Aiello A, Repele F, Falasca L, Francalancia M, Garbuglia AR, Delogu G, Nicastri E, Piacentini M, Goletti D. Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants. Cell Death Discov 2022;8:288. [PMID: 35705564 DOI: 10.1038/s41420-022-01080-8] [Reference Citation Analysis]
2 Iacopetta D, Ceramella J, Catalano A, Saturnino C, Pellegrino M, Mariconda A, Longo P, Sinicropi MS, Aquaro S. COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies. Viruses 2022;14:573. [DOI: 10.3390/v14030573] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]